These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
678 related articles for article (PubMed ID: 14727923)
1. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment. Wang Z; Zhou J; Lu X; Gong Z; Le XC Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923 [TBL] [Abstract][Full Text] [Related]
2. Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective. Lin CJ; Wu MH; Hsueh YM; Sun SS; Cheng AL Cancer Chemother Pharmacol; 2005 Feb; 55(2):170-8. PubMed ID: 15322825 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide. Fujisawa S; Ohno R; Shigeno K; Sahara N; Nakamura S; Naito K; Kobayashi M; Shinjo K; Takeshita A; Suzuki Y; Hashimoto H; Kinoshita K; Shimoya M; Kaise T; Ohnishi K Cancer Chemother Pharmacol; 2007 Mar; 59(4):485-93. PubMed ID: 16937107 [TBL] [Abstract][Full Text] [Related]
5. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3. Šlejkovec Z; Podgornik H; Černelč P; Falnoga I Biometals; 2016 Feb; 29(1):107-18. PubMed ID: 26671504 [TBL] [Abstract][Full Text] [Related]
6. Speciation of arsenic trioxide penetrates into cerebrospinal fluid in patients with acute promyelocytic leukemia. Kiguchi T; Yoshino Y; Yuan B; Yoshizawa S; Kitahara T; Akahane D; Gotoh M; Kaise T; Toyoda H; Ohyashiki K Leuk Res; 2010 Mar; 34(3):403-5. PubMed ID: 19733394 [TBL] [Abstract][Full Text] [Related]
7. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species. Aposhian HV; Zakharyan RA; Avram MD; Sampayo-Reyes A; Wollenberg ML Toxicol Appl Pharmacol; 2004 Aug; 198(3):327-35. PubMed ID: 15276412 [TBL] [Abstract][Full Text] [Related]
8. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats. Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413 [TBL] [Abstract][Full Text] [Related]
9. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds. Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427 [TBL] [Abstract][Full Text] [Related]
10. Trivalent arsenicals are bound to proteins during reductive methylation. Naranmandura H; Suzuki N; Suzuki KT Chem Res Toxicol; 2006 Aug; 19(8):1010-8. PubMed ID: 16918239 [TBL] [Abstract][Full Text] [Related]
11. Stability of arsenic species and insoluble arsenic in human urine. Chen YC; Amarasiriwardena CJ; Hsueh YM; Christiani DC Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1427-33. PubMed ID: 12433722 [TBL] [Abstract][Full Text] [Related]
12. Speciation analysis of arsenic in urine samples from APL patients treated with single agent As Guo M; Li J; Fan S; Liu W; Wang B; Gao C; Zhou J; Hai X J Pharm Biomed Anal; 2019 Jul; 171():212-217. PubMed ID: 31009876 [TBL] [Abstract][Full Text] [Related]
13. Effects of endogenous hydrogen peroxide and glutathione on the stability of arsenic metabolites in rat bile. Kobayashi Y; Hirano S Toxicol Appl Pharmacol; 2008 Oct; 232(1):33-40. PubMed ID: 18619986 [TBL] [Abstract][Full Text] [Related]
14. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755 [TBL] [Abstract][Full Text] [Related]
15. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic. Soto-Reyes E; Del Razo LM; Valverde M; Rojas E Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750 [TBL] [Abstract][Full Text] [Related]
16. Analytical artefacts in the speciation of arsenic in clinical samples. Slejkovec Z; Falnoga I; Goessler W; van Elteren JT; Raml R; Podgornik H; Cernelc P Anal Chim Acta; 2008 Jan; 607(1):83-91. PubMed ID: 18155413 [TBL] [Abstract][Full Text] [Related]
17. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan. Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952 [TBL] [Abstract][Full Text] [Related]
18. A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment. Sweeney CJ; Takimoto C; Wood L; Porter JM; Tracewell WG; Darwish M; D'Andrea DM; Remick SC Cancer Chemother Pharmacol; 2010 Jul; 66(2):345-56. PubMed ID: 19911123 [TBL] [Abstract][Full Text] [Related]
19. Electrospray ionization tandem mass spectrometric determination of monomethylarsonic acid and dimethylarsinic acid after adduct formation with citric acid. Minakata K; Ohnishi K; Nakamura S; Suzuki M; Suzuki O J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2624-9. PubMed ID: 19329367 [TBL] [Abstract][Full Text] [Related]
20. Impact of arsenic in foodstuffs on the people living in the arsenic-affected areas of West Bengal, India. Mandal BK; Suzuki KT; Anzai K J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1741-52. PubMed ID: 17952775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]